Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Olive S. Pettengill is active.

Publication


Featured researches published by Olive S. Pettengill.


Cancer | 1980

Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung

Olive S. Pettengill; George D. Sorenson; Doris H. Wurster-Hill; Thomas J. Curphey; Walter W. Noll; Charles C. Gate; L. Herbert Maurer

Sixteen continuous tumor‐cell cultures have been isolated from 91 tissue specimens from patients with small‐cell carcinoma of the lung. Biopsy and autopsy specimens of primary and metastatic tumors have been utilized. The developing cell lines were recognized by proliferation of tumor cells in the culture from one to 14 weeks after explantation and have been maintained for up to four years. Primary lung tumor, bone marrow aspirations, pleural effusions and other metastases have all been productive explant material for the development of cell lines. Their human origin has been demonstrated by chromosome and/or isoenzyme analysis. Dense core vesicles, characteristically found in small‐cell tumor cells were observed by electron microscopic examination of cultured cells. Growth rates in vitro have been measured and the in vitro cycle time in tumors of one cell line (DMS 79) has been compared with in vivo cycle time in tumors arising from DMS 79 cells in nude athymic mice.


Regulatory Peptides | 1982

Bombesin production by human small cell carcinoma of the lung

George D. Sorenson; Stephen R. Bloom; M. A. Ghatei; Salvatore A. Del Prete; Charles C. Cate; Olive S. Pettengill

A series of continuous cell lines of human small cell carcinoma of the lung (SCCL) have been evaluated for the production of bombesin (BN). In early established cultures BN was detected in the medium of 9 out of 11 cell lines and in 6 out of 7 cell homogenates examined. Levels in the medium were frequently higher in cultures of later passages compared to earlier passages of the same line and low levels developed in the two previously negative cell lines. Plasma concentrations were greater than 80 pmol/l in 2 out of 27 (7%) randomly selected patients with SCCL. A culture (DMS 406) established from the tumor of a patient with the highest plasma level (1240 pmol/l) was the highest producer in vitro. The results indicate that BN, which has been demonstrated immunocytochemically to be present in normal bronchial mucosal cells, is frequently produced by SCCL in vitro but elevated plasma levels are infrequently found in patients with this neoplasm.


Cancer Genetics and Cytogenetics | 1984

Cytogenetics of small cell carcinoma of the lung

Doris H. Wurster-Hill; Linda A. Cannizzaro; Olive S. Pettengill; George D. Sorenson; Charles C. Cate; L. Herbert Maurer

Nineteen cell lines derived from various malignant tissues of 15 patients with small cell carcinoma of the lung (SCCL) have been studied. The results showed heterogeneity in all cell lines, with no one consistent abnormality among them. Cell lines from 11 of the patients had minute and double minute chromosomes, and cell lines from 2 patients had abnormally banding regions, designated as ABRs, as distinguished from homogeneously staining regions (HSRs). The latter 2 and several of the former cell lines were derived from specimens taken before the patients were placed on therapy. All but 2 of the cell lines had a constant marker load, consisting of 24%-35% of the complement. Some markers remained stable through months and years of culture life, while other markers came and went. Chromosomes #1, #6 and #11 were most frequently involved in marker formation in the cell lines, and these were compared to similar markers in direct bone marrow preparations. Chromosome #1 markers were of variable structure, whereas #6 and #11 most often took the form of 6q- and 11p+ markers, with breakpoints most frequently at 6q23-25 and 11p11-12. A 3p- marker was found in a minority of cell lines. All of these markers were also found in direct marrow preparations from some patients with SCCL. Nonmonoclonal tumors arose from inoculation of bimodal cell lines into nude mice, but population selection by undetermined mechanism was evident. Cytogenetic parameters showed no positive correlation with hormone production by these cell lines.


Life Sciences | 1983

Bombesin and calcitonin secretion by pulmonary carcinoma is modulated by cholinergic receptors

George D. Sorenson; Olive S. Pettengill; Charles C. Cate; M. A. Ghatei; Kathryn E. Molyneux; Edmund J. Gosselin; Stephen R. Bloom

Three established cell lines derived from human small cell carcinoma of the lung, and known to produce significant amounts of peptide hormones were used to evaluate the regulation of hormone secretion by cholinergic agonists. In two of the cell lines (DMS 53, DMS 153) acetylcholine chloride, bethanechol chloride, and carbamylcholine at the concentrations of 10(-3)M to 10(-5)M stimulated secretion of bombesin and calcitonin as measured by RIA. The third cell line, DMS 406, was not significantly stimulated. Inhibition of induced stimulation by the cholinergic antagonist atropine, but not hexamethonium, indicated the presence of muscarinic rather than the nicotinic type of cholinergic receptors on the stimulatable cells. These receptors appear to mediate hormone secretion comparably to normal endocrine cells.


Cytogenetic and Genome Research | 1974

Giemsa-banded chromosomes of mouse myeloma in relationship to oncogenicity.

J.S. Shepard; Doris H. Wurster-Hill; Olive S. Pettengill; George D. Sorenson

G-banded karyotypes (413 in all) of the hypotetraploid mouse myeloma MOPC-21 and five cell lines isolated at different times, of the MOPC-315 tumor and a cell line, and of the X5563 tumor were compare


Genomics | 1989

Mapping and characterization of an X-linked processed gene related to MYCL1

Cynthia C. Morton; Michel C. Nussenzweig; Rui Sousa; George D. Sorenson; Olive S. Pettengill; Thomas B. Shows

A DNA sequence with homology to the myc family of proto-oncogenes has been characterized and found to be a processed gene related to L-MYC (MYCL1). This processed gene (MYCL2) was isolated by cross-hybridization to an oligonucleotide probe synthesized from the C-MYC (MYC) sequence in a highly conserved region of the myc gene family. Sequence analysis of MYCL2 revealed an open reading frame of 1194 bp with no intervening sequences and strong homology to the recently published DNA sequence of MYCL1. Southern and Northern blot analyses of DNAs and RNAs from small cell lung carcinomas confirmed its MYCL1 homology. Mapping of MYCL2 by somatic cell hybrids places this sequence on the long arm of the X chromosome in bands q22----q28.


Cancer Genetics and Cytogenetics | 1990

Hypodiploid, pseudodiploid, and normal karyotypes prevail in cytogenetic studies of medullary carcinomas of the thyroid and metastatic tissues

Doris H. Wurster-Hill; Olive S. Pettengill; Walter W. Noll; Sarah H. Gibson; Truls Brinck-Johnsen

Medullary carcinoma of the thyroid (MCT), often a dominantly inherited neoplasm, derived from intrathyroid C-cells of neural crest origin, is one of the solid tumors least studied cytogenetically. The cells are difficult to grow in culture, only two cell lines having ever been established. Cytogenetic studies of only 5 tumors have been reported previously. In this paper we report on the cytogenetic analyses of 8 specimens of primary and/or metastatic MCT tumor tissue from 6 patients with familial disease, including more recent metastatic tumors in lymph node and femur of a patient whose thyroid and earlier lymph node metastases were described previously. Some of these specimens were harvested sequentially over time. Hypodiploid or diploid modal numbers prevailed with normal, pseudodiploid, or hypodiploid karyotypes.


Pancreas | 1998

Azaserine-Induced Rat Pancreas Tumor Model with Transplantable Cultured Cells

Kimmo Mäkinen; Sami Loimas; Veli-Matti Kosma; Jarmo Wahlfors; Olive S. Pettengill; Daniel S. Longnecker; Risto Johansson; Esko Alhava

The purpose of this study was to describe the inoculation technique and patterns of growth as well as to characterize typical histological features of Lewis rat subcutaneous and intrapancreatic tumors, induced by inoculation of cultured pancreatic cancer cells (DSL-6A/C1). Subcutaneous inoculation of cultured cells produced a solid tumor that was a locally invasive, well- to moderately differentiated ductal adenocarcinoma. Tumor take was 100% in animals 5 weeks of age; tumor growth was consistent and predictable and a tumor volume of −1 cm3 was reached in 8 weeks. After intrapancreatic transplantation the tumors showed the same histological features as subcutaneous tumors. During inoculation carcinoma cells easily spread around the injected area, and after 2 weeks both pancreatic tumors and superficially infiltrating carcinomas were found in the liver and spleen and around the peritoneum. Tumor take was 60% and tumor growth was somewhat indefinite and unpredictable in the pancreas. However, by reducing the injected carcinoma cell volume and solving the technical problems, 100% tumor take was achieved. The tumor volume reached 2 mm3 during 2 weeks and larger tumors showed a tendency for invasion. According to our results, subcutaneous as well as intrapancreatic tumor induction with cultured cells offers a model for pancreatic cancer studies.


Cancer Immunology, Immunotherapy | 1986

Lysis of small cell carcinoma of the lung tumor cell lines by gamma interferon-activated allogeneic peripheral blood mononuclear cells: abrogation of killing by pretreatment of tumor cells with gamma interferon

Edward D. Ball; Kim E. Nichols; Olive S. Pettengill; George D. Sorenson; Michael W. Fanger

SummaryInterferon has been shown to enhance the ability of nonspecific cytotoxic mononuclear cells to lyse some, but not all, tumor cells. We have examined the effect of recombinant human gamma interferon (rIFNγ) on the cell-mediated cytolysis of tumor target cells derived from continuously cultured lines of small cell carcinoma of the lung (SCCL). Cells from the SCCL lines DMS 44, 53, 79, 92, and 406 were labeled with 51Cr and incubated with normal and rIFNγ-stimulated peripheral blood mononuclear cells for 18 h at 37 °C and tumor cell lysis estimated by measuring 51Cr release. Although cells from certain SCCL lines were good targets for cell mediated cytotoxicity, susceptibility to lysis was heterogenous among the different SCCL lines. DMS 406 and 79 were, on average, maximally lysed, while DMS 44, 53, and 92 showed less susceptibility to lysis by either control or rIFNγ-stimulated effector cells. In addition, although pretreatment with rIFNγ increased the cytolytic capacity of normal peripheral blood mononuclear cells from several different donors, preincubation of the tumor cell lines with rIFNγ resulted in inhibition of cytolysis mediated by both control and IFN-activated effector cells. These findings suggest that although rIFNγ may enhance cell-mediated lysis of SCCL tumor cells, it may also decrease susceptibility to lysis.


Journal of Steroid Biochemistry | 1979

Estrogen production by an established cell line from pulmonary small cell anaplastic carcinoma

Truls Brinck-Johnsen; Olive S. Pettengill; K. Brinck-Johnsen; G.D. Sorenson; L.H. Maurer

Radioimmunoassays demonstrated the presence of estradiol-17β in growth medium from DMS-44, a continuous cell line obtained from pulmonary small cell anaplastic carcinoma; other steroids such as testosterone and cortisol were not present in measurable amounts. To study further the ability of DMS-44 cells to produce estrogens, [3H]-testosterone or [3H]-androstenedione was incubated with cells for 24 h. [3H]-estrone and [3H]-estradiol-17β were isolated from the incubation medium by extraction. Partition and thin layer chromatography. The two estrogens were identified by chromatography after addition of authentic [14C]-estrone to the fractions presumed to contain [3H]-estrone and authentic [14C]-estradiol-17β to that of [3H]-estradiol. Estradiol-17β was favored over estrone as the main estrogen formed both from testosterone and androstenedione. The estradiol-17β fraction was repeatedly chromatographed in several thin layer Chromatographic systems, reaching constant Tritium: Carbon-14 ratio. These findings, together with the radioimmunoassay data, are considered conclusive evidence for the formation of estradiol-17β by small cell carcinoma cell lines in vitro.

Collaboration


Dive into the Olive S. Pettengill's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Edward D. Ball

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bernard J. Poiesz

State University of New York System

View shared research outputs
Top Co-Authors

Avatar

Berton Zbar

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge